Skip to main content

Table 1 Correlation of RUNX3 mRNA expression with the clinicopathological factors of esophageal cancer patients

From: Elevated expression of RUNX3 co-expressing with EZH2 in esophageal cancer patients from India

Clinicopathological parameters No. of patients RUNX3 expression relative to β-Actin p-value
Age    
 ≥ 50 44 4.26 ± 4.9 0.351
 < 50 13 5.28 ± 5.4  
Sex    
 Male 32 5.34 ± 4.4 0.711
 Female 25 4.68 ± 6.4  
TNM Classification    
 Locally advanced resectable 28 5.05 ± 5.8  
 Locally advanced unresectable 25 5.04 ± 5.2 0.728
 Metastatic 4 5.13 ± 2.8  
Dysphagia Grade    
 dys Gr1 1 4.09 ± 0  
 dys Gr2 19 5.25 ± 5.8  
 dys Gr3 24 4.92 ± 5.2 0.359
 dys Gr4 11 6.48 ± 3.1  
 dys Gr5 2 -2.6 ± 9.05  
Location of Tumor    
 Upper third 7 7.88 ± 3.1  
 Middle third 25 4.78 ± 4.6 0.272
 Lower third 25 4.53 ± 6.2  
Smoking    
 Smoker 32 5.46 ± 4.7 0.742
 Non-smoker 25 4.53 ± 6.04  
Alcohol    
Alcoholic 21 5.5 ± 3.7 0.967
 Non-Alcoholic 36 4.79 ± 6.1  
 Tobacco    
 Tobacco Chewer 5 7.62 ± 4.1 0.438
 Non-Tobacco Chewer 52 4.81 ± 5.4  
Type    
 SCC 51 5.12 ± 5.5 0.153
 Adeno 6 4.45 ± 2.6  
Diet    
 Non Veg 31 5.39 ± 4.1 0.866
 Veg 26 4.77 ± 6.2